載入...
The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A ‘hypothesis-generator’ study from clinical practice
The most frequent site of recurrence in breast cancer (BC) is the bone, particularly in patients with ‘luminal-like’ disease. Denosumab has been shown to prevent aromatase inhibitors (AIs) induced bone resorption in postmenopausal early BC patients and reduce skeletal-related events (SREs) in bone m...
Na minha lista:
發表在: | Oncol Lett |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
D.A. Spandidos
2018
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6256706/ https://ncbi.nlm.nih.gov/pubmed/30546457 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.9561 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|